Labcorp Launches Companion Diagnostic For Amgen’s Newly-Approved Lung Cancer Therapy
Labcorp® (NYSE:LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to identify patients with